Cite
HARVARD Citation
Stalder, A. et al. (n.d.). Biomarker‐guided clinical development of the first‐in‐class anti‐inflammatory FPR2/ALX agonist ACT‐389949. British journal of clinical pharmacology. pp. 476-486. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stalder, A. et al. (n.d.). Biomarker‐guided clinical development of the first‐in‐class anti‐inflammatory FPR2/ALX agonist ACT‐389949. British journal of clinical pharmacology. pp. 476-486. [Online].